The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALB.L Regulatory News (ALB)

  • There is currently no data for ALB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8 - Bionex Investments

9 Mar 2005 16:14

W.H. Ireland Limited9 March 2005 Date of Disclosure 9TH MARCH 2005 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 8TH MARCH 2005 Dealing in BIONEX INVESTMENTS PLC (name of company) 1) Class of securities (eg ordinary shares) ORDINARY 0.01P 2) Amount bought Amount sold Price per unit 750,000 1.6P 3) Resultant total of the same class owned or controlled (and percentage of class) 24,316,667 (15.4%) 4) Party making disclosure W H IRELAND LIMITED 5) EITHER (a) Name of purchaser/vendor (Note 1) MRS S VANDYK OR (b) if dealing for discretionary client(s), name of fund management organisation 6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) J F MOLYNEUX Telephone and extension number 020 7397 3065 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, eg where an owner normally acts on instructions of a controller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or which an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8 Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed. Note 7. The resultant total percentage holding of the class of relevant security is to be calculated by reference to the percentage held and in issue outside treasury. For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. Email: monitoring@disclosure.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Mar 20187:01 amRNSSignificant Customer Win
12th Mar 20187:00 amRNSFull Year Results
22nd Feb 20187:00 amRNSPilot Project with Leading Global Ad Agency
8th Feb 20182:34 pmRNSAlbert CEO Or Shani Wins 2018 BIG Innovation Award
23rd Jan 20182:00 pmRNSMao Keo joins Albert Technologies
9th Jan 20187:00 amRNS2017 Update and Capital Markets Dinner
22nd Dec 20177:00 amRNSExercise and Grant of Options
5th Dec 20174:40 pmRNSSecond Price Monitoring Extn
5th Dec 20174:35 pmRNSPrice Monitoring Extension
5th Dec 20177:00 amRNSSaaS Update & Cessation of Indirect Business
25th Sep 20177:00 amRNSAlbert Technologies Interim Results
27th Jul 20177:01 amRNSStrategic Partnership - Australia and New Zealand
27th Jul 20177:00 amRNSTrading update
12th Jul 201712:04 pmRNSCompany name change
26th Jun 20177:00 amRNSExercise of Options
22nd Jun 20172:17 pmRNSResult of AGM
15th May 20177:02 amRNSPDMR Shareholding
15th May 20177:01 amRNSNotice of AGM and Grant of Options
15th May 20177:00 amRNSPosting of Annual Report
10th Apr 20177:00 amRNSPDMR Shareholdings
7th Apr 201711:05 amRNSSecond Price Monitoring Extn
7th Apr 201711:00 amRNSPrice Monitoring Extension
3rd Apr 20177:01 amRNSDirector Appointment
3rd Apr 20177:00 amRNSFull Year Results
17th Mar 20177:00 amRNSSignificant Customer Win
14th Feb 20177:00 amRNSDirectorate Change
1st Feb 20177:00 amRNSTrading Update
18th Jan 20174:40 pmRNSSecond Price Monitoring Extn
18th Jan 20174:35 pmRNSPrice Monitoring Extension
26th Oct 20165:40 pmRNSExercise of Options
27th Sep 20167:00 amRNSDirector/PDMR Shareholdings
19th Sep 20167:00 amRNSInterim results
14th Sep 20162:05 pmRNSSecond Price Monitoring Extn
14th Sep 20162:00 pmRNSPrice Monitoring Extension
7th Jul 201611:10 amRNSResult of AGM
13th Jun 20162:30 pmRNSNotice of AGM and Grant of Options
27th Apr 201612:38 pmRNSPosting of Annual Report
14th Apr 20167:00 amRNSFinal Results for the year ended 31 December 2015
15th Feb 20167:00 amRNSHolding(s) in Company
10th Feb 20164:41 pmRNSSecond Price Monitoring Extn
10th Feb 20164:35 pmRNSPrice Monitoring Extension
31st Dec 20157:00 amRNSDirector Share Transfer
23rd Dec 20152:17 pmRNSDirector/PDMR Shareholding
17th Dec 20157:00 amRNSTrading and Business Review
9th Oct 20157:00 amRNSTrading Update
7th Sep 20152:05 pmRNSResult of EGM
13th Aug 20157:00 amRNSNotice of EGM
3rd Aug 20157:00 amRNSInterim Results
11th Jun 20157:00 amRNSFirst day of dealings on AIM
16th Jul 200911:00 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.